New drug may shield brain during delicate aneurysm procedures
NCT ID NCT06238115
Summary
This study tested whether adding a short-term drug called tirofiban during procedures to treat unruptured brain aneurysms could better prevent small strokes compared to the standard two-drug antiplatelet regimen. It involved 192 adults undergoing stent-assisted coiling or flow diversion. Researchers compared the number and size of new brain lesions on scans after the procedure between the two groups.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FLOW DIVERTER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Tiantan Hospital
Beijing, China
Conditions
Explore the condition pages connected to this study.